MESAS

A group of world leading clinicians, scientists and methodologists that support organisations to answers health-related questions on clinical, research, decision-making, industry and legal matters

SERVICES

We provide world class consultancy to answer your health-related questions.

MESAS can also serve as a SME partner in EU funding applications. 

FOUNDERS

With a wealth of experience across various medical specialties and research methodologies, our founders are dedicated to delivering the highest quality insights and recommendations.
Take a look at their publications

Dr Marco Solmi

Prof. Marco Solmi

Marco Solmi, MD, psychiatrist, PhD, is Associate Professor and Director of Research, Department of Psychiatry, University of Ottawa, Canada, Medical Director of On Track First Episode Psychosis program and of the Eating Disorders program, The Ottawa Hospital, Scientist, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité University Medicine Berlin, visiting academic at University of Southampton, School of psychology and King’s College, IoPPN, Psychosis Department, UK, and affiliate at the METRIC center, Stanford University, USA. He is Chair of ECNP Physical And meNtal Health (PAN-Health) Thematic Working Group (TWG), and member of other European and Canadian psychiatric associations.

He is interested in meta-research and epidemiology, to study prevention/early interventions, psychopharmacology, and physical health in those with mental disorders.

He authored over 550 publications in leading medical journals, and is among Clarivate Highly Cited Researchers in Psychiatry and Psychology since 2021.

Follow on

Dr Veronese Nicola

Prof. Nicola Veronese

Prof. Nicola Veronese, MD, is a certified trained geriatrician, currently working as Associate Professor in Geriatrics and Internal Medicine at the University of Palermo, Italy. He is also Professor at the King Saud University, Saudi Arabia. His research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, his interest areas are osteoarticular, metabolic (including obesity and diabetes) and cardiovascular diseases, as well as nutrition, frailty and sarcopenia.

He is the Editor in Chief of Aging Clinical and Experimental Research and Associate Editor of Age and Ageing (systematic reviews) and involved as member of several scientific journals.

He is the author of more than 700 articles published in national and international scientific journals, and of numerous abstracts accepted by national and international congresses. He is among Clarivate Highly Cited Researchers in Psychiatry and Psychology in 2023 and named as Rising Star in Medicine (20th in the World).

Follow on

Prof. Brendon Stubbs

Dr Brendon Stubbs research focuses on lifestyle interventions, notably physical activity and health.  Since 2019, Dr Stubbs has been ranked as one of the world’s most influential mental health researchers according to Clarivate™. Brendon has published over 800 academic papers, including European and World Psychiatric Association guidelines.  His research has been cited over 65,000 times and informed many national and international policies (e.g. WHO guidelines).  Brendon holds multiple academic positions at leading Universities, including King’s College London.  Dr Stubbs has also held senior (board level) positions at MedTech companies including Chief Scientific and Clinical Safety Officer.  

Brendon’s research is frequently featured in multiple International media outlets such as the New York Times, TIME magazine, Forbes, CNN, Women’s Health, Men’s Health, BBC news, ITV news and Sky News (among others).  Dr Stubbs was the lead scientist for the documentary Mind Games which featured in over 30 countries. 

Dr Stubbs has given over 250 invited International talks to numerous audiences, including business leaders at the World Economic Forum, major sporting events (French Open), large sports brands (e.g. ASICS) and multinational companies (e.g. Amazon).  Dr Stubbs also works as a consultant for many business International businesses that seek to embed evidence-based solutions to demonstrate the impact of their offering. 

Follow on

SCIENTIFIC AND ADVISORY BOARD

To ensure the highest standards of excellence in our services, we’ve assembled a distinguished Scientific and Advisory Board composed of world-renowned experts in the field of human health. Our board members bring a wealth of experience and expertise to our team, guiding our work in evidence synthesis, research design, data analysis, and strategic consulting.

Colin Jones

Colin Jones is a Senior Data Scientist specializing in inferential data science, with a focus on opening black boxes and enabling transparent, evidence-based decision-making. He builds predictive models for time series analysis, longitudinal data, and mixed-effects models, with financial, economic, and psychometric applications. Colin is currently completing a PhD in Data Science at Carleton University and holds a Master of Science in Statistics from Western University.
Colin Jones is a Senior Data Scientist and PhD candidate in Data Science at Carleton University, where he conducts research under the supervision of Dr. Dave Campbell. His doctoral work focuses on the detection and treatment of influential outliers in general machine learning models, with an emphasis on improving model transparency and trustworthiness in high-stakes decision-making contexts. Colin specializes in inferential data science, with broad expertise in probabilistic machine learning, time series forecasting, mixed-effects modeling, and applications in finance and economics. His work often addresses the challenge of “opening black boxes” by combining statistical inference with modern predictive modeling, enabling more interpretable and robust outcomes. He has published in peer-reviewed journals and received multiple academic research awards recognizing both the theoretical and applied impact of his work. Colin’s recent projects span large-scale data analysis, the generation and evaluation of synthetic data, and scalable Bayesian methods for modeling complex data environments. He holds a Master of Science in Statistics from Western University, and has developed and deployed models in both academic and industry settings, often working with high-dimensional and large datasets. His passion lies in bridging the gap between statistical rigor and machine learning performance to support evidence-based, transparent decision-making.

Prof. Pinar Soysal

Pinar Soysal, Professor of Geriatric Medicine at Bezmialem Vakıf University, Istanbul, specializes in geriatric syndromes, dementia, malnutrition, frailty, and polypharmacy. With 300+ publications, she co-leads the European Geriatric Medicine Society's Dementia SIG and recently completed Harvard's Clinical Research Leadership program in 2024.
Pinar Soysal is a certified trained geriatrician, currently working as a Professor in the Department of Geriatric Medicine at Bezmialem Vakıf University, Istanbul, Türkiye. Her research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, her interest areas are common geriatric syndromes, dementia, malnutrition, frailty, and polypharmacy. She is the author of more than 300 articles published in national and international scientific journals and of numerous abstracts accepted by national and international congresses. She has been a co-leader of the Dementia Special Interest Group in the European Geriatric Medicine Society for three years. She also graduated from Harvard Medical School’s Clinical Research Leadership program at the beginning of 2024.
Dr. Gianluca Lollo

Dr. Gianluca Lollo

Dr Gianluca Lollo, MD, Gastroenterologist, is the Head of Service responsible for the Department of Gastroenterology and Endoscopic Surgery at the Hospital S.Giovanni of Bellinzona (Ticino in Switzerland), using cutting-edge technology in a large volume of endoscopic procedures as first operator. He is also involved in several research projects.
Dr Gianluca Lollo, MD, Gastroenterologist, is specialized in diseases of digestive system at the University Polyclinic Hospital of Padua (Italy). He continued his studies with focus on advanced endoscopic techniques with Prof. A. Repici at the Humanitas Research Hospital in Rozzano, Milan (Italy). Currently he is working as Head of Service responsible for the Department of Gastroenterology and Endoscopic Surgery at the Hospital S.Giovanni of Bellinzona (Ticino in Switzerland), performing over 15.000 cases as first operator. He is registered at Swiss Society of Gastroenterology (SGGSSG) and he is member and treasurer of Association of Gastroenterologists of Italian Switzerland (AGASI). He is also working as a collaborator at University of Italian Switzerland SUPSI in Lugano (Switzerland) and with different important centers. He developed experience in advanced endoscopy techniques, both in and surgery and diagnostic fields (he performed over 1000 ERCP using new system of cholangioscopy for lithotrisie of big stone and in malignant cases inside main and pancreatic duct). He also has strong knowledge and skills in complex cases of resection colon/upper-gastriIntestinal lesions (i.g. performing complex polypectomies with new techniques performing endoscopic submucosal dissection ‘ESD’, full-thickness resection ‘FTRD’, in total over 600 procedures). He performed treatment of Zenker’s diverticulum with flexible endoscopic. Furthermore, he uses ultrasound endoscopy ‘EUS’ in diagnostic procedures for malignant pancreatic at biliary system using needle biopsy/cytology (FNB-FNA) performing over 500 procedures; in particular he developed new endoscopy advance technique during drainage of liquid collection/walled off necrosis post acute pancreatitis using lumen apposite metal stent (LAMS.called Hot axios) for necrosectomy endoscopic. He also authored of publication in leading scientific journals, in particular on the operational and diagnostic side with use of the first AI systems during colorectal cancer screening.“

Dr. Francesco Di Gennaro

Francesco Di Gennaro, Associate Professor of Infectious and Tropical Diseases at the University of Bari, Italy, has authored 130 scientific articles. Editor for journals like BMC Infectious Diseases, he leads research projects in Ethiopia, Uganda, and Mozambique, focusing on antibiotic resistance, HIV, TB, COVID-19, and vulnerable populations.
Francesco Di Gennaro is an Associate Professor of Infectious and Tropical Diseases at the University of Bari “Aldo Moro”, Italy. He is the author of 130 scientific articles published in international journals. He serves as an editor for several scientific journals, including BMC Infectious Diseases and Frontiers in Public Health. He is responsible for international research projects in Ethiopia, Uganda, and Mozambique. His research focuses include antibiotic resistance, HIV, TB, COVID-19, vulnerable populations, and developing countries.
Dr Rebecca Bendayan

Dr. Rebecca Bendayan

Dr. Rebecca Bendayan, Affiliate Researcher at King’s College London and CEO of Analytics for Change, specializes in integrating AI-based technology into healthcare models, focusing on mental health and aging. A Fellow of the UK Higher Education Academy, she leads innovative projects ensuring compliance with Equity, Diversity, and Inclusivity policies.
Dr. Rebecca Bendayan holds a PhD in Psychology, a MSc Research in Health Psychology, a MSc in Research Methods for Behavioral and Health Sciences, is a Fellow of the UK Higher Education Academy, and an ONS Accredited Researcher. She has led innovation projects in top UK universities and she is an expert advisor in health informatics for life science and health technology. Her research focuses on improving methods to integrate AI-based technology in health care models ensuring compliance with Equity, Diversity, Inclusivity policies and she is passionate about applications in mental health and ageing. She is an Affiliate Researcher, Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neurosciences, King’s College London, as well as Founder and CEO, at Analytics for Change.
Prof Christopher U Correll

Prof. Christoph U. Correll

Christoph U. Correll, MD, is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He is a global key opinion leader in psychiatry and psychopharmacology.
Christoph U. Correll, MD, is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York. Since 1997, he has been working and conducting research in New York, USA, and since 2017 he is also working in Germany again. Dr. Correll focuses on the identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-research, and the interface between physical health and mental health. He has authored or co-authored over 900 journal articles that have been cited more than 80.000 times and received over 40 research awards for his work. In July 2024, his H-index was 143 in Google Scholar. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry” (https://hcr.clarivate.com). Additionally, Dr. Correll has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including being ranked consistently since 2017 as the number one cited world expert in >10 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum and other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.
Dr Kristina Curtis

Dr. Kristina Curtis

A behavioral scientist with 10+ years' experience bridging academia and industry, specializing in digital health solutions to improve outcomes. Expert in public health, weight management, medication adherence, and employee well-being. Honorary Lecturer at UCL’s Centre for Behavior Change, delivering teaching and supervising PhDs in digital health innovation.
A pioneering behavioural scientist with over a decade of experience working in the intersection between academia and industry. A trailblazer in integrating scientific evidence and creative methods into innovative digital health solutions. Expert in driving adoption and engagement with digital health interventions to improve health outcomes. Extensive experience developing digital health interventions and communications in the areas of public health service uptake; weight management; medication adherence; physical activity; chronic disease self-management; and employee well-being. Honorary Lecturer & Associate at UCL’s Centre of Behaviour Change where she delivers regular teaching and PhD supervision.
Dr Michael Sand

Dr. Michael Sand

Michael, with 35 years in pharmaceutical clinical science, specializes in mental illness drug development. He has 160+ publications in human sexuality and psychopharmacology and advised the DSM-V Committee. Currently, he consults for biotech companies and serves on the NIMH AMP-Schizophrenia Steering Committee.
Michael has 35 years’ experience as a clinical scientist in the pharmaceutical industry, focused on developing novel compounds for serious mental illness. He has authored or co-authored over 160 peer-reviewed abstracts, papers and book chapters in human sexuality and psychopharmacology and served as a Work Group Advisor to the DSM-V Committee on Sexual and Gender Identity Disorders. He currently serves as a consultant to a number of pharmaceutical and biotech companies as well as to the NIMH, where he is on the Steering Committee of the AMP-Schizophrenia initiative. In his spare time, he is an avid hiker, biker, skier and sailor. He lives in Monroe, Connecticut with his wife and a border collie who he fears is smarter than he is.
Dr. Arya Rahgozar

Dr. Arya Rahgozar

Arya Rahgozar, scientist at OHRI and adjunct professor at uOttawa, specializes in NLP, semantic text classification, and ontology learning. With a Ph.D. in Digital Transformation, 20+ years in analytics, and roles in eHealth projects like iCARE Parkinson and dementia predictions, his work bridges AI, medicine, and healthcare innovation.
Arya Rahgozar is a scientist at OHRI and an adjunct Professor of Data Science at the School of Electrical Engineering and Computer Science and was a Postdoctoral Fellow at the School of Medicine, DFM, University of Ottawa. He received his Ph.D. in Digital Transformation and Innovation from the University of Ottawa, specializing in Natural Language Processing (NLP) under Prof. Diana Inkpen’s supervision, specifically in multi-lingual semantic text classification, clustering and ontology learning. Arya got his master’s from the University of Waterloo in Management Sciences, specialized in graph process modelling with temporal event predictions, NLP. Arya has over 20 years of decision science, analytics industrial experience and partnerships in banking, credit risk, marketing, healthcare and supply-chain, as an advanced analytics team leader and principal Data Scientist. Arya was a Mitacs primary investigator and a start-up partner to develop Chat-bot Recommender systems. Arya is a prime AI co-investigator in variety of eHealth projects: NLP application in Brain-Heart Interconnectome, iCARE Parkinson, BMRI Dementia, eConsult and Frailty predictions. Arya’s research interests are in NLP, machine understanding, their applications in medicine, and eHealthcare.
Riccardo Panella MESAS

Riccardo Panella

With over 10 years of experience in developing new therapeutic approaches based on RNA medicine and in preclinical to clinical transition he has translate his discoveries in clinical therapeutic approach.
Co-Founder & Chief Scientific Officer, Resalis Therapeutics, Associate Professor, Center for RNA Medicine, Aalborg University, Head of RNA core and Coordinator of Research Activities at European Biomedical Research institute of Salerno. Riccardo Panella is an expert in RNA-based drug development, specializing in antisense oligonucleotide (ASO) therapeutics and non-coding RNA targeting. As Co-Founder and Chief Scientific Officer of Resalis Therapeutics, he drives the development of new therapeutic approaches in obesity and metabolic disorders. His work focuses on advancing oligonucleotide-based therapies from preclinical validation to clinical translation, securing strategic pharma partnerships and guiding the company’s scientific vision. In parallel, Panella is Associate Professor at Aalborg University’s Center for RNA Medicine and the head of RNA core at EBRIS, where he leads a research group investigating non-coding RNA in metabolic homeostasis and RNA-targeted therapeutic strategies. Prior, he was Assistant Research Professor at the Desert Research Institute (Reno, NV), studying RNA-based interventions in cancer metabolism, and spent six years at Harvard Medical School’s Cancer Center, where he contributed to RNA-targeting drug discovery. Panella has authored multiple patents and peer-reviewed publications in the field of oligonucleotide therapeutics and is a frequent invited speaker at international conferences focused on RNA therapeutics, metabolism, and ASO-based drug development at the verge between science and entrepreneurship
Dr. Lee Smith

Prof. Lee Smith

Professor Lee Smith holds the position of Professor of Public Health at Anglia Ruskin University, UK. He is a public health scientist with international recognition in several areas including physical activity, sedentary behaviour, mental health, sexual health, geriatric medicine, and population health. He has published over 900 scientific publications.
Professor Lee Smith holds the position of Professor of Public Health at Anglia Ruskin University, UK. He is trained in epidemiology and is a public health scientist with international recognition in several areas including physical activity, sedentary behaviour, mental health, sexual health, geriatric medicine, and population health. He is also internationally recognised for, and world-leading in, the meta-analytic techniques that he employees within his research. To date, he has published other 900 peer-reviewed scientific publications in world leading journals such as the British Medical Journal and World Psychiatry. Over the past two years he was listed as a Clarivate highly cited researcher (world top 1%).

Dr. Josh Firth

Dr. Josh Firth, Associate Professor at the University of Leeds and Visiting Fellow at Oxford, integrates behavioral science, ecology, and computational biology to study interactions between individuals and environments. Recognized internationally, Dr. Firth applies advanced analytical methods to real-world challenges in health, conservation, and epidemiology, with extensive interdisciplinary publications.
Dr. Josh Firth holds a PhD in Biology from the University of Oxford, and is currently an Associate Professor at the University of Leeds and a Visiting Research Fellow at the University of Oxford. Dr Josh Firth’s research integrates behavioral science, ecology, and computational biology for understanding the interactions between individuals, environments, and societies, using advanced analytical methods within large datasets from natural populations. Dr. Josh Firth is internationally recognized for their contributions to applied and theoretical science, having designed and implemented novel approaches across disciplines including ecology, epidemiology, conservation, and health science. Dr Josh Firth has a strong track record of applying fundamental science to real world impact; During the COVID-19 pandemic, Dr. Josh Firth served on the UK Government’s SPI-M group (the modeling arm of SAGE), using computational methods for assessing how social networks shape disease spread. Dr Josh Firth also holds experience with working within Industry, particularly in biological data science, and specializes in translating statistical methods into applied health outcomes, particularly in relating to advancing health and nutrition research. Dr. Josh Firth has published extensively across fields, including social networks, computational biology, epidemiology and health. Recently, Dr. Josh Firth led the Royal Society’s workshop and special issue on the interplay between age and society, again employing diverse methods for fostering interdisciplinary dialogue.

REQUEST MESAS SERVICES